Overall Survival After177lu-Psma-617 Molecular Radiotherapy In Patients With Metastatic Castrate-Resistant Prostate Cancer: Post-Hoc Analysis Of A Prospective Phase Ii Trial
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING(2020)
摘要
5549Background: This was an open-label randomized prospective bi-centric single-arm phase II clinical trial of 177Lu-PSMA-617 molecular radiotherapy in patients with progressive metastatic castrate...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要